Testing FIT-DNA to guide follow-up after colon cancer surgery
Part of Cancer, Digestive system clinical trials.
This trial checks a stool test called FIT-DNA after colorectal (colon) cancer surgery. It aims to see whether this test can help doctors monitor for recurrence during follow-up and decide how closely to watch.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with colorectal adenocarcinoma (a common type of colon cancer)
- You are between 18 and 80 years old and can take part in follow-up visits
- You need curative (radical) colorectal surgery, and scans before surgery did not show spread to distant organs
- You did not receive cancer treatment before surgery (like chemo, radiation, targeted drugs, or immunotherapy)
- You don’t have major ongoing stomach or rectal bleeding issues before surgery (for example, severe hemorrhoids)
- You agree to sign consent and follow the study’s follow-up plan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how well a set of bacterial gene markers (a DNA-like test) can help identify advanced “precancer-like” or higher-risk growths in the colon. It may help doctors better target who needs closer follow-up during colonoscopy.
This trial offers free screening for colorectal cancer using a stool test for people aged 45-74. It is for those who haven't had certain colorectal tests recently and are generally healthy.
This study compares two ways of checking for colorectal cancer risk after advanced polyps are removed. It may help determine whether a stool test can safely replace some colonoscopy surveillance for certain people.
This study checks a “cell-free tumor DNA” blood test to see if cancer mutations can predict relapse after surgery for early colorectal cancer. If results look risky, they may help guide closer follow-up and future treatment decisions.
This study looks at a blood “DNA” test to see if it can help monitor colorectal cancer after surgery. It may benefit you by improving how doctors track cancer during routine follow-up visits.
This trial is testing a new way to screen for colorectal cancer in adults aged 45 to 74. If you join, you will help researchers find better methods for early detection.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.